Cerliponase Alfa

CAS 1688275-21-8 1 FDA-DMF supplierBiologic

Overview

Cerliponase Alfa is a recombinant form of human tripeptidyl peptidase 1 (TPP1) used in enzyme replacement therapy for treating Batten disease, specifically CLN2 type. It acts by supplementing the deficient enzyme in patients, slowing disease progression.

Therapeutic areas

NeurologyGenetic Disorders

Related APIs

Nusinersen
9 suppliers
Onasemnogene Abeparvovec
1 suppliers
Aripiprazole
45 suppliers
Pregabalin
40 suppliers
Levetiracetam
37 suppliers
Lurasidone Hydrochloride
35 suppliers
Lamotrigine
33 suppliers
Lacosamide
33 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo